Comparison of Hybritech and WHO standardization applied to access Hybritech total PSA assay on UniCel®

Rivista Italiana della Medicina di Laboratorio

Volumn 4, Issue 1, 2008, Pages 43-46

  Stenner, Elisabetta ^a   Micheli, W ^a   Bussani, A ^b   Gotti, A ^a   Biasioli, B ^a  

^a UNIVERSITY HOSPITAL OF TRIESTE   (Italy)

^b ISTITUTO NAZIONALE DI OCEANOGRAFIA E DI GEOFISICA SPERIMENTALE OGS   (Italy)

Author keywords

Cut off; Hybritech; Prostate carcinoma; WHO96 670

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CALIBRATION; CALIBRATOR; CONTROLLED STUDY; HEALTH CARE ORGANIZATION; PSA ASSAY;

EID: 54049137666     PISSN: 1825859X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Catalona WJ, Hudson MA, Scardino PT, Richie JP, Ahmann FR, Flanigan RC, et al. Selection of optimal prostate specific antigen cut-offs for early detection of prostate cancer: receiver operating characteristic curves. J Urol 1994;152:2037-42.
2. Semjonow A, De Angelis G, Oberpenning F, Schmid P, Brandt B, Hertle L. The clinical impact of different assays for prostate specific antigen. BJU Int 2000; 86:590-7.
3. Stamey TA. Second Stanford Conference on International Standardization of Prostate-Specific Antigen Immunoassays: September 1 and 2, 1994. Urology 1995; 45:173-84.
4. Stamey TA, Teplow DB, Graves HC. Identity of PSA purified from seminal fluid by different methods: comparison by amino acid analysis and assigned extinction coefficients. Prostate 1995; 27:198-203.
5. Kort SA, Martens F, Vanpoucke H, van Duijnhoven HL, Blankenstein MA. Comparison of 6 automated assays for total and free prostate-specific antigen with special reference to their reactivity toward the WHO 96/670 reference preparation. Clin Chem 2006; 52:1568-74.
6. Stephan C, Klaas M, Müller C, Schnorr D, Loening SA, Jung K. Interchangeability of measurements of total and free prostate-specific antigen in serum with 5 frequently used assay combinations: an update. Clin Chem 2006; 52:59-64.
7. Stephan C, Kramer J, Meyer HA, Kristiansen G, Ziemer S, Deger S, et al. Different prostate-specific antigen assays give different results on the same blood sample: an obstacle to recommending uniform limits for prostate biopsies. BJU Int 2007; 99:1427-31.
8. Dorizzi RM, Meneghelli S, Rizzotti P, Giavarina D. Differences of prostate-specific antigen assays: a small light at the end of the tunnel? Ann Clin Biochem 2006; 43:420-1.
9. Roddam AW, Rimmer J, Nickerson C, Ward AM. Prostate-specific antigen: bias and molarity of commercial assays for PSA in use in England. Ann Clin Biochem 2006; 43:35-48.
10. Semjonow A, Oberpenning F, Brandt B, Zechel C, Brandau W, Hertle L. Impact of free prostatie-specific antigen on discordant measurement results of assays for total prostate-specific antigen. Urology 1996; 48S:10-5.
11. Vignati G, Giovanelli L. Standardization of PSA measures: a reappraisal and an experience with WHO calibration of Beckman Coulter Access Hybritech total and free PSA. Int J Biol Markers 2007; 22:295-301.